Psychedelic Assisted Psychotherapy (PAP)
Psychedelic-assisted psychotherapy (PAP) involves the professionally supervised use of ketamine, MDMA, psilocybin, LSD and ibogaine as part of elaborated therapeutic programs.
PAP is widely viewed as the most radical innovation in the treament of mental health issues in decades. Clinical results so far have shown safety and efficacy, even for “treatment resistant” conditions, and thus deserve increasing attention from medical, psychological and psychiatric professionals. But more than novel treatments, the PAP model also has important consequences for the diagnostics and explanation axis of the psychiatric crisis, challenging the discrete nosological entities and advancing novel explanations for mental disorders and their treatment, in a model considerate of social and cultural factors, including adversities, trauma, and the therapeutic potential of some non-ordinary states of consciousness.